MedTrace Logo

A Comparison of PR Oxycodone/Naloxone and PR Oxycodone After Cardiac Surgery

NCT01374763 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2012-02-20

No results posted yet for this study

Summary

The aim of the study is to describe the effects of oxycodone/naloxone combination in comparison to oxycodone for the treatment of postoperative pain in patients undergoing cardiac surgery. The hypothesis is that the duration of opioid-induced bowel dysfunction and the need of laxatives will decrease.

Conditions

  • Postoperative Pain
  • Opioid Related Disorders

Interventions

DRUG

Oxycodone

Prolonged-release oxycodone 10-30 mg twice daily

DRUG

Prolonged-release oxycodone/naloxone

Prolonged-release oxycodone/naloxone 10-30 mg twice daily

Sponsors & Collaborators

  • Kati Järvelä

    lead OTHER

Principal Investigators

  • Kati Järvelä, MD, PhD · Tampere University Hospital Heart Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01374763 on ClinicalTrials.gov